{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:12:57Z","timestamp":1788459177861,"version":"build-2803163510"},"reference-count":53,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hematopoietic stem cell transplantation (HSCT) is vital for treating blood disorders, yet Low- and Middle-Income Countries (LMICs) often lack adequate Bone Marrow Transplant (BMT) pharmacy services. This study aims to reach consensus among oncology pharmacy experts on the essential staff, infrastructure, supplies, and safety\/control measures required to establish BMT pharmacy services in LMICs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>The Delphi method was employed to evaluate and achieve consensus on BMT pharmacy services at Benjamin Mkapa Hospital in Tanzania, involving 11 oncology pharmacy personnel.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the initial round, participants responded to 10 open-ended questions concerning staffing, infrastructure, supplies, medicines, safety, and quality assurance. The second round focused on achieving consensus, breaking down the domains into 14 specific points. Consensus scores varied from 64% (neutral) for safety and quality assurance to 96% for staffing levels, with consensus reached at 66.7%. The third round concentrated on prioritization, identifying staffing and infrastructure as high priorities, which received a score of 46%. Safety and quality assurance garnered the lowest score at 9%. Participants proposed two guidelines, three protocols, and 21 standard operating procedures (SOPs). Additionally, they suggested 14 essential medicines, 56 adjunctive medicines, 22 medical devices, and at least two Class III biosafety cabinets, which are crucial for establishing BMT pharmacy units and HSCT services in resource-limited settings. These resources were categorized into those already established at BMH and those that emerged from participant consensus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The Delphi findings highlight staffing and infrastructure as top priorities for establishing BMT and HSCT services in resource-limited settings. Addressing safety and quality assurance is also crucial. The recommended guidelines and protocols can enhance service delivery and improve patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10781552261481538","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:19:51Z","timestamp":1788275991000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Establishing comprehensive oncology-haematology pharmacy care for paediatric bone marrow transplantation in sickle cell disease: Procedural insights from a Delphi study conducted in Tanzania"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4833-8142","authenticated-orcid":false,"given":"Kauke Bakari","family":"Zimbwe","sequence":"first","affiliation":[{"name":"The Benjamin Mkapa Hospital"},{"name":"Clinical Trials and Pharmacovigilance Section, Human and Veterinary Medicines Directorate, Tanzania Medicines and Medical Devices Authority, Dodoma, Tanzania"},{"name":"University of Antwerp"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Simon","family":"Shau","sequence":"additional","affiliation":[{"name":"The Benjamin Mkapa Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3741-031X","authenticated-orcid":false,"given":"Yusto Julius","family":"Yona","sequence":"additional","affiliation":[{"name":"The Benjamin Mkapa Hospital"},{"name":"National Institute of Transport"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Philemon","family":"Bura","sequence":"additional","affiliation":[{"name":"The Benjamin Mkapa Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mkapa Faustine","family":"Madebele","sequence":"additional","affiliation":[{"name":"The Benjamin Mkapa Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"e_1_3_3_2_2","unstructured":"Parikh Purvish M Shah Pankaj M Lalit EJK. Hematopoietic Stem Cell Transplantation In India. 2002;136\u201349. https:\/\/www.mohfw.gov.in\/sites\/default\/files\/Hematopoietic%20Stem%20Cell%20Transplantation%20In%20India.pdf."},{"key":"e_1_3_3_3_2","unstructured":"Koda-Kimble MA Young LY. Applied Therapeutics: the clinical use of drugs 9th edition. 2008."},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2008.06.018"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-53626-8"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2021.103057"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15092452"},{"key":"e_1_3_3_8_2","doi-asserted-by":"crossref","unstructured":"Malno\u00eb D Lamande T Bail Al et al. Therapeutic pathways of allogeneic and autologous hematopoietic stem cell transplantation recipients\u202f: a hospital pharmacist \u2018 s perspective To cite this version\u202f: HAL Id\u202f: hal-04649932 Therapeutic pathways of allogeneic and autologous hematopoietic stem. 2024.","DOI":"10.30827\/ars.v65i3.30246"},{"key":"e_1_3_3_9_2","first-page":"1","volume-title":"Principles and overview of allogeneic hematopoietic stem cell transplantation. Vol. 144, cancer treatment and research","author":"Giralt S","year":"2009","unstructured":"Giralt S, Bishop MR. Principles and overview of allogeneic hematopoietic stem cell transplantation. Vol. 144, cancer treatment and research. Springer Netherlands, 2009, pp.1\u201321."},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-44080-9_13"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000722"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-023-02135-9"},{"key":"e_1_3_3_13_2","first-page":"344","volume-title":"Conditioning regimens for hematopoietic cell transplantation: one size does not fit all. Vol. 124, blood","author":"Gyurkocza B","year":"2014","unstructured":"Gyurkocza B, Sandmaier BM. Conditioning regimens for hematopoietic cell transplantation: one size does not fit all. Vol. 124, blood. American Society of Hematology, 2014, p.344\u2013353."},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018016956"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-02278-5"},{"key":"e_1_3_3_16_2","first-page":"1339","article-title":"Pharmaceutical services and inpatient drug costs in bone marrow transplantation","volume":"51","author":"King PS","year":"1994","unstructured":"King PS, Wordell CJ, Haupt BA. Pharmaceutical services and inpatient drug costs in bone marrow transplantation. Am J Hosp Pharm 1994; 51: 1339\u20131342.","journal-title":"Am J Hosp Pharm"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-023-01951-3"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad033"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269216317690685"},{"key":"e_1_3_3_20_2","doi-asserted-by":"crossref","unstructured":"Jorm A. Using the Delphi Method to Establish Expert Consensus Advancing Methods for Interdisciplinarity in the Social Sciences https:\/\/doi.org\/10.1007\/978-981-96-8357-4_1.","DOI":"10.1007\/978-981-96-8357-4_1"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-026-02126-y"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1988.03410120089033"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-021-01298-z"},{"issue":"29","key":"e_1_3_3_24_2","first-page":"1","article-title":"Establishing kidney transplantation in a low-income country: a case in Tanzania","volume":"10","author":"Furia FF","year":"2024","unstructured":"Furia FF, Shoo JG, Ruggajo PJ, et al. Establishing kidney transplantation in a low-income country: a case in Tanzania. Ren Replace Ther 2024; 10(29): 1\u20138.","journal-title":"Ren Replace Ther"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024014879"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.042622"},{"key":"e_1_3_3_27_2","volume-title":"Current Approaches for the Prevention and Treatment of Acute and Chronic GVHD. Vol. 13, Cells","author":"Olivieri A","year":"2024","unstructured":"Olivieri A, Mancini G. Current Approaches for the Prevention and Treatment of Acute and Chronic GVHD. Vol. 13, Cells. Multidisciplinary Digital Publishing Institute (MDPI), 2024."},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017008375"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2025.103738"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13739"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers18010124"},{"key":"e_1_3_3_32_2","unstructured":"The Administration of Mesna with Ifosfamide and Cyclophosphamide Clinical Guideline V4.0. 2025."},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.5917-20"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-024-02207-4"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2033122"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/MCC.0000000000000587"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26041132"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2024.09.015"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S493670"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018016956"},{"key":"e_1_3_3_41_2","article-title":"Treatment of graft versus host disease with photopheresis interferes in voriconazole therapeutic drug monitoring: a case study","volume":"37","author":"Sassone A","year":"2023","unstructured":"Sassone A, Testard J, Saulo A, et al. Treatment of graft versus host disease with photopheresis interferes in voriconazole therapeutic drug monitoring: a case study. Pract Lab Med [Internet] 2023; 37: e00340. Available from: https:\/\/doi.org\/10.1016\/j.plabm.2023.e00340.","journal-title":"Pract Lab Med [Internet]"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/tid.14094"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1007\/s44313-025-00081-7"},{"key":"e_1_3_3_44_2","doi-asserted-by":"crossref","unstructured":"Battah MM Zainal H Ibrahim A et al. Evaluation of Antiemetic Consistency in Chemotherapy-Induced Nausea and Vomiting Among NHL Patients in Sana \u2018 a Yemen. 2024;(May):2077\u201390.","DOI":"10.2147\/IJGM.S458922"},{"key":"e_1_3_3_45_2","unstructured":"Berger MJ Anand S Barbour S et al. NCCN Guidelines Version 2.2022 Antiemesis Continue NCCN Guidelines Panel Disclosures \u03be Bone marrow transplantation \u2021 Hematology\/ Hematology oncology \u00de Internal medicine \u2020 Medical oncology # Nursing \u03a3 Pharmacology \u00a3 Supportive care including palliative pain management pastoral care and oncology social work * Discussion section committee member. 2022. https:\/\/www.nccn."},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac306"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.2500.2500"},{"key":"e_1_3_3_48_2","unstructured":"Health Building Note 02-01 Cancer treatment facilities [Internet]. http:\/\/www.nationalarchives.gov.uk\/doc\/open-government-licence\/. 2013."},{"key":"e_1_3_3_49_2","first-page":"85","volume-title":"The chapter <800>answer book","author":"Kienle PC","year":"2019","unstructured":"Kienle PC, editor. Design of compounding facilities. In: The chapter <800>answer book. American Society of Health-System Pharmacists, 2019, pp.85\u201386."},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-03-0666"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/tid.14236"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1111\/tid.14169"},{"key":"e_1_3_3_53_2","first-page":"6828","volume-title":"Vol. 13, Journal of Clinical Medicine","author":"Delandre O","year":"2024","unstructured":"Delandre O, Pradines B, Javelle E. Dihydroartemisinin\u2013Piperaquine Combination in the Treatment of Uncomplicated Plasmodium falciparum Malaria: Update on Clinical Failures in and Tools for Surveillance. In: Vol. 13, Journal of Clinical Medicine. Multidisciplinary Digital Publishing Institute (MDPI), 2024, p.6828."},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.102922"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552261481538","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10781552261481538","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552261481538","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:18:21Z","timestamp":1788455901000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10781552261481538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":53,"alternative-id":["10.1177\/10781552261481538"],"URL":"https:\/\/doi.org\/10.1177\/10781552261481538","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"article-number":"10781552261481538"}}